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A 54-year-old woman was admitted for cough, sputum, and an abnormal chest X-ray
shadow. Bronchoscopy showed mucoid impaction of the bronchi (MIB†). Histopathologic
evidence of mucous plugs was consistent with one component of allergic bronchopulmonary
mycosis. Schizophyllum commune (S. commune) was identified. Two attempts at removal
of the mucous plugs were unsuccessful. Itraconazole was then administered, and the mu-
cous plugs disappeared. There are few reports of MIB due to S. commune; we herein report
a case of MIB due to S. commune infection.
INTRODUCTION
Mucoid impaction of the bronchi
(MIB) is an uncommon condition indicat-
ing segmental and subsegmental bronchi
characterized by the dilatation and filling
of bronchi with characteristic thick mucoid
material. MIB is believed to occur most
commonly as a manifestation of a hyper-
sensitivity state in bronchial asthma or in
association with allergic bronchopul-
monary mycosis (ABPM). In this report,
we describe a patient in whom Schizophyl-
lum commune (S. commune) caused MIB,
which improved with itraconazole (ITCZ)
administration. S. commune is a basid-
iomycetes fungus found throughout Japan,
commonly in dry logs, dead wood, and
fallen trees. S. commune is considered edi-
ble in Peru or Thailand; however, in Japan,
it recently has been identified as a causative
agent of MIB andABPM.There are limited
reports of pulmonary involvement due to S.
commune, and we believe the case is worth
reporting.
CASE
A 54-year-old woman was referred to
Saitama Cardiovascular and Respiratory
Center in August 2000 for investigation of
*To whom all correspondence should be addressed: Takashi Ishiguro, Saitama Cardiovas-
cular and Respiratory Center, 1696 Itai Kumagaya City, Saitama, Japan; E-mail:
ishiguro@med3.m.kanazawa-u.ac.jp.
†Abbreviations: MIB, mucoid impaction of the bronchi;.ABPM, allergic bronchopulmonary
mycosis; ITCZ, itraconazole; ABPA: allergic bronchopulmonary aspergillosis.a cough, sputum, and an abnormal chest X-
ray shadow. The cough and sputum had de-
veloped in December 1999 and had not
improved. The patient had no relevant per-
sonal or family history. Physical examina-
tion did not reveal any abnormalities,
including wheezes.
Chest X-ray showed bilateral, hilar
band-like shadows (Figure 1a). Computed
tomography (CT) of the chest showed mu-
cous plugs in both B3 bronchi and consoli-
dation (indicating atelectasis) in the
peripheral part of the mucous plugs (Figure
1b,c). Pulmonary function tests did not in-
dicate bronchial asthma. Laboratory tests
showed a white blood cell count of
3,400/mm3, with 9.5 percent eosinophils
(323/ﾵl). Radioimmunosorbent test showed
the IgE concentration to be within normal
limits, and results of radioallergosorbent test
for specific IgE antibodies against As-
pergillus, Cladosporium, Candida, and
Cryptococcus were all negative. No inflam-
matory reactions, assessed by the C-reactive
protein level and erythrocyte sedimentation
rate, were observed. Bronchoscopy dis-
closed thick white mucous plugs in both B3
bronchi (Figure 2a,b) that could not be re-
moved by forceps and suctioning. Removal
was attempted again on another day but
failed. Higher magnification of the mucous
plug sample showed numerous eosinophils
(Figure 3a). Grocott staining of the mucous
plug sample showed mold with a frag-
mented appearance (Figure 3b). Trans-
bronchial lung biopsy specimens showed
infiltration of eosinophils in the wall of the
right upper lobe bronchus. From the third to
tenth day after cultivation, cultures of the
mucous plugs, bronchial aspirates, and spu-
tum samples yielded the same mycelial
colonies, which were white and had a felt-
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Figure 1.
a. Chest X-ray
film obtained
upon admission
showing patchy
opacification in
both right upper
lung fields.
b,c. Computed
tomography scan
of the chest
showing
bronchiectasis
and mucoid im-
paction in the
right B3 (b) and
left B3 (c)
bronchi.
Figure 2.
Bron-
choscopy
showed
mucoid im-
paction in
the right
B3 (a) and
in left B3
bronchi
(b).like, fluffy appearance on Sabouraud dex-
trose agar plates (Figure 4a); however, no
other pathogenic microorganisms were iso-
lated. A methane-like odor was observed.
With regard to form, there were narrow and
thin walls approximately 1.5 mm in width,
as well as wide and thick walls approxi-
mately 2.5 mm in width, with separate hy-
phae but no clamp connection. Considering
the feature of colonies, form, odor, and the
two types of hyphae in the colony, we hy-
pothesized that it was a monokaryotic strain
of S. commune.We consulted the Chiba Uni-
versity Research Center for Pathogenic
Fungi and Microbial Toxicoses for identifi-
cation of the fungus. Mating tests were per-
formed [1,2,3].The clinical isolate was inoc-
ulated onto plates opposite each tester
monokaryotic strain of S. commune, wherein
it was dikaryotized and a fruit body was
formed at the point of contact (Figure 4b).
When co-cultured with a dikaryotic strain, it
was dikaryotized and produced basidio-
carps. From the foregoing, this fungus was
identified as a monokaryotic mycelium of S.
commune.At a later time, the presence of S.
commune in the patient’s garden was con-
firmed (Figure 6).
ABPM, as well as ABPA (allergic
bronchopulmonary aspergillosis), usually is
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Figure 3.
Photomicrograph (a)
of the mucous plug
drained bronchoscopi-
cally shows numerous
eosinophils and Char-
cot’s-Leiden crystals
(arrow) (a. hema-
toxylin and eosin
stain). Fragment like
fungal hyphae (arrow)
were detected in the
mucous plug sample
(b. Grocott stain).
x400
Figure 4. Cultures of mucous plug samples, bronchial aspirates, and sputum samples ob-
tained by bronchoscopy yielded the same mycelial colonies, which were white and had a
felt-like, fluffy appearance on Sabouraud dextrose agar plates (a). White-yellow, fan-
shaped basidiocarps of S. commune grew on a plate of Sabouraud dextrose agar (b) as a
result of the mating test. They appeared 36 days after mating.diagnosed on the basis of Rosenberg’s
seven primary criteria [4]: (1) episodic
bronchial obstruction (asthma); (2) periph-
eral blood eosinophilia; (3) immediate
scratch test reactivity to Aspergillus anti-
gen; (4) precipitating antibodies to As-
pergillus antigen; (5) elevated serum IgE
concentrations; (6) history of pulmonary in-
filtrates (transient or fixed); and (7) central
bronchiectasis. The diagnosis of ABPM is
considered likely if the first six criteria
were present, and the presence of all seven
made the diagnosis certain. The present
case satisfied only two (the second and the
sixth criteria) of seven criteria (neither the
third nor the fourth criteria were investi-
gated because of methodological limita-
tion), and diagnosis ofABPM cannot be es-
tablished.We diagnosed the patient as MIB
due to S. commune infection.
Complete removal of the mucous plugs
by bronchoscopy was attempted twice un-
successfully, and the patient was treated with
ITCZ for three months, beginning in Sep-
tember 2000. The cough improved and spu-
tum diminished, and in December 2000,
bronchoscopy disclosed that the mucous
plugs had disappeared. Bronchoscopy was
repeated in July 2001, January 2002, and
2003, and there has been no recurrence of
the mucous plugs (Figure 5) or symptoms.
The patient has been followed up on an out-
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Figure 5.
Bronchoscopy
showed a
patent bronchial
lumen after ad-
ministration of
itraconazole
200 mg daily.
Figure 6. A photomicrograph shows that Schizophyllum commune was found on a tree in
the patient’s garden.patient basis for seven years and has shown
no signs of recurrence.
DISCUSSION
We encountered a case of MIB due to
S. commune infection. ITCZ was adminis-
tered, and the mucous plugs disappeared.
MIB occurs commonly in association
with ABPM, and it is known that there is
clinical overlap between MIB and ABPM
[5,6,7]. ABPM/MIB is considered to be the
result of an immunologic inflammatory re-
action in the bronchi and the surrounding
parenchyma in response to antigens (fungi)
growing in mucous plugs in the airways.
The major causative agents of ABPM/MIB
are Aspergillus fumigatus and other As-
pergillus spp (Allergic bronchopulmonary
aspergillosis; ABPA); reports of
ABPM/MIB due to S. commune are limited.
The reasons we speculate are as follows: (1)
its pathogenic significance is not well under-
stood; and (2) isolation and identification of
S. commune is difficult [8]. It is not easy to
identify this fungus only by using patholog-
ical samples or smears. This fungus appears
in a clavate form in smears, and it is difficult
to discriminate morphologically from fila-
mentous fungi such as Aspergillus spp. In-
deed, in some previous cases, S. commune
was morphologically misidentified as As-
pergillus [2,9,10]. Kamei and colleagues re-
ported that 12 percent of undetermined
pathologic fungi obtained in clinical speci-
mens were S. commune and urged consider-
ation of its pathogenic significance [8].
Therefore, it is possible that the frequency
ofABPM/MIB due to S. commune has been
underestimated. The presence of S. com-
mune infection should be investigated in
case of ABPM/MIB in which the antibody
against Aspergillus fumigatus is negative or
Aspergillus fumigatus is not detected in the
sputum or in specimens obtained in the air-
way.
The present case was diagnosed clini-
cally as MIB, notABPM. Katzenstein noted
pathologically that MIB or bronchocentric
granulomatosis with eosinophil infiltration
into the tissue strongly suggests ABPM or
ABPA, and the diagnosis is established
when fungal hyphae are recognized in the
mucous plug [11].The present case was his-
tologically characterized by numerous
eosinophils, Charcot’s-Leiden crystals, hy-
phae in the mucous plugs, and infiltration of
eosinophils in the wall of the right upper
lobe bronchus; thus, the present case can be
diagnosed as ABPM histologically. How-
ever, in most cases, the diagnosis ofABPM
not due to Aspergillus was clinically based
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Ref Author Age Sex Diagnosis Treatment
Table 1. Previous Reports of Lung Infection of Schizophyllum commune
1994 8 Kamei 57 F ABPM ITCZ
1996 4 Sigler 53 F fungus ball Lobectomy
1996 9 Rihs 58 M lung abscess AMPH, FLCZ, ITCZ
1996 3 Amitani 67 F MIB Bronchial toilet
1996 10 Tomita 72 F ABPM AMPH, ITCZ
1997 11 Ikushima 53 F ABPM AMPH, steroid
1997 6 Yamashina 44 F ABPM AMPH, steroid
2001 12 Ito 51 F MIB ITCZ
2002 13 Yamazaki 79 F ABPM steroid
2003 14 Kawano 27 F ABPM steroid
2003 14 Kawano 33 F ABPM steroid
2007 present case Ishiguro 54 F MIB ITCZ
ABPM: Allergic bronchopulmonary mycosis; ITCZ: Itraconazole; AMPH: amphotericin B; FLCZ: fluconazole;
MIB: mucoid impaction of the bronchi.on Rosenberg’s criteria as well asABPA. In
the present case, although peripheral blood
eosinophilia was found, allergic component
including elevated serum IgE concentration
and bronchial asthma was not found. In ad-
dition, there were some criteria that could
not be investigated because of methodolog-
ical limitation. In such cases, Rosenberg’s
criteria should not be applied. There are
other diagnostic criteria for ABPA used in
the United Kingdom [12], including asthma,
pulmonary eosinophilia (fleeting shadow on
the chest radiograph in association with a
peripheral blood or airway eosinophilia),
and a positive immediate skin prick test to A.
fumigatus; however, the criteria also were
not satisfied (the third criterion could not in-
vestigated), so this case clinically cannot be
diagnosed asABPM.
Reports of pulmonary involvement due
to S. commune are limited. To our knowl-
edge, 13 cases (including the present case)
have been reported (Table 1). Among the
13 were seven cases of ABPM, one of a
fungus ball, one of a lung abscess, and four
of mucoid impaction (including the present
case). Patients were predominantly female
(female:male, 12:1), and 11 of 13 patients
were over 40 years of age. The reason for
the predominance of middle-aged female
patients remains unknown. In addition,
seven of the patients had bronchial asthma
(53.8 percent). Kamei and colleagues re-
ported eight cases ofABPM due to S. com-
mune, only 30 percent of which were
accompanied by bronchial asthma, and they
suggested that the frequency of bronchial
asthma may be lower in ABPM due to S.
commune than inABPA[8].Agreater num-
ber of reported cases is necessary to clarify
this matter.
Kamei and colleagues postulated that
underlying diseases of the lower respiratory
tract such as old tuberculosis, bronchial
asthma, and malignancy often exist in the
patients withABPM due to S. commune, but
noted there are patients without any underly-
ing disorder [8]. Therefore, S. commune in-
fection can develop in any patient, with or
without underlying diseases. In the present
case, the patient had no underlying disease.
There are no reports that S. commune
infection develops more frequently in indi-
viduals in any specific environment or job
such as mushroom culture, in which
causative fungi are easily inhaled. In the
present case, however, S. commune was
growing in the garden at the patient’s house.
MIB has been treated effectively by re-
peated bronchoscopic drainage [1], washing
with Amphotericin B, and bronchoscopic
suctioning [3,9,15]. In this case, however,
two attempts to remove the mucous plug
were unsuccessful. Subsequent administra-
tion of ITCZ 200 mg daily resulted in symp-
tomatic relief and disappearance of the
mucous plugs.
ABPM/MIB is a state formed when
pathogens and biological immune responses
become entangled in a complex way.The al-
lergic aspect of ABPM/MIB has been
stressed, and steroid therapy generally is
used for allergic aspect ofABPM/MIB [19-
21]; however, an infectious aspect has re-
cently been recognized on the basis of the
effectiveness of antifungal therapy for
ABPA [10,22] and histopathologic findings
[23]. The present case improved with ITCZ
administration without steroid therapy,
which may indicate that the infectious aspect
was more likely than the allergic aspect in
this case. However, the histological findings
of the mucous plugs characterized by nu-
merous eosinophils, Charcot’s-Leiden crys-
tals, and infiltration of eosinophils in the
wall of the right upper lobe bronchus
strongly suggested allergic background. It is
possible ITCZ reduced S. commune, an al-
lergic antigen, which resulted in attenuated
allergic reaction; therefore, an allergic as-
pect should have co-existed. It is therefore
difficult to differentiate clearly infection
from allergic reaction.
Kamei reported a recurrence after a pe-
riod of improvement with itraconazole 50-
100 mg daily [1]; thus, long-term follow-up
is necessary.
In summary, we report a case of MIB
due to S. commune infection. The most fre-
quent causative fungus of ABPM is known
to be Aspergillus fumigatus; however, S.
commune should be added to the differential
110 Ishiguro: Schizophyllum commune and mucoid impaction of the bronchidiagnosis in case of MIB, especially if mold
is found in the specimen with no evidence
of Aspergillus fumigatus. An antifungal
agent may be useful in the treatment of MIB
due to S. commune.
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